Lala Ceklic

Lala Ceklic is a Research Fellow and Grader at the University of Bern's Department of Ophthalmology since 2011, based at Inselspital, Universitätsspital Bern. She specializes in retinal imaging and clinical research, with expertise in optical coherence tomography (OCT) and multimodal imaging for managing diabetic macular edema, retinal vein occlusion, and age-related macular degeneration.

Her educational background includes:

• Ophthalmology residency at Inselspital, Universitätsspital Bern (2011-2016)
• Ophthalmology residency at University of Novi Sad (2004-2007)
• Training at International Council of Ophthalmology (2003-2004)

Dr. Ceklic's research focuses on predictive biomarkers for treatment response in retinal diseases, with recent work examining gender-specific differences in disease presentation and real-world outcomes of anti-VEGF therapy. Her expertise in OCT analysis drives investigations into structural changes during disease progression and treatment, particularly for diabetic macular edema and retinal vein occlusion where personalized treatment approaches are critical.

Analysis of her 2022-2024 publications reveals a strategic shift toward translational research, connecting imaging biomarkers with clinical outcomes. Her work increasingly addresses health disparities through gender medicine frameworks while maintaining technical rigor in imaging methodology.

Dr. Ceklic's scientific contributions are recognized through:

• ARVO Kreissig Foundation Travel grant (2012)
• Helmerich Foundation Scholarship (2011)
• American Academy of Ophthalmology Rotary Program Scholarship (2010)
• Austrian-American/Soros Foundation Scholarship (2008)
• European Society of Ophthalmology Scholarship (2007)

She actively contributes to the Fight Retinal Blindness! international registry and RADIANCE clinical trial through Bern's imaging reading center. Her collaborative network spans 15+ countries, enabling high-impact studies on treatment standardization. While direct student supervision isn't documented, her role in training graders for multicenter trials provides significant mentorship opportunities in clinical research methodology.

Dr. Ceklic is integral to the university's retinal imaging core facility, which standardizes OCT analysis for clinical trials and supports drug development pipelines. Her team specializes in biomarker discovery from complex imaging datasets, directly influencing therapeutic decision-making in retinal medicine.